Surgery
Volume 146, Issue 5 , Pages 939-946 , November 2009

Tissue-type plasminogen activator prevents abscess formation but does not affect healing of bowel anastomoses and laparotomy wounds in rats with secondary peritonitis

  • Otmar R. Buyne, MD

      Affiliations

    • Department of Surgery, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
    • ,
  • Robert P. Bleichrodt, MD, PhD

      Affiliations

    • Department of Surgery, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
    • ,
  • Ben M. De Man

      Affiliations

    • Department of Surgery, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
    • ,
  • Roger M.L.M. Lomme

      Affiliations

    • Department of Surgery, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
    • ,
  • Paul E. Verweij, MD, PhD

      Affiliations

    • Department of Medical Microbiology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
    • ,
  • Harry van Goor, MD, PhD

      Affiliations

    • Department of Surgery, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
    • ,
  • Thijs Hendriks, PhD

      Affiliations

    • Department of Surgery, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
    • Corresponding Author InformationReprint requests: Thijs Hendriks, PhD, Department of Surgery, Radboud University Nijmegen Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.

,Accepted 22 April 2009.

References 

  1. Farthmann EH, Schoffel U. Epidemiology and pathophysiology of intraabdominal infections (IAI). Infection. 1998;26:329–334
  2. Marshall JC. Intra-abdominal infections. Microbes Infect. 2004;6:1015–1025
  3. Wong PF, Gilliam AD, Kumar S, Shenfine J, O'Dair GN, Leaper DJ. Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults. Cochrane Database Syst Rev. 2005;CD004539
  4. Vermeulen J, Akkersdijk GP, Gosselink MP, Hop WC, Mannaerts GH, van der HE, et al. Outcome after emergency surgery for acute perforated diverticulitis in 200 cases. Dig Surg. 2007;24:361–366
  5. Breitenstein S, Kraus A, Hahnloser D, Decurtins M, Clavien PA, Demartines N. Emergency left colon resection for acute perforation: primary anastomosis or Hartmann's procedure? A case-matched control study. World J Surg. 2007;31:2117–2124
  6. Marshall JC, Innes M. Intensive care unit management of intra-abdominal infection. Crit Care Med. 2003;31:2228–2237
  7. Schein M. Surgical management of intra-abdominal infection: is there any evidence?. Langenbeck Arch Surg. 2002;387:1–7
  8. Ince A, Eroglu A, Tarhan O, Bulbul M. Peritoneal fibrinolytic activity in peritonitis. Am J Surg. 2002;183:67–69
  9. Reijnen MM, Bleichrodt RP, van GH. Pathophysiology of intra-abdominal adhesion and abscess formation, and the effect of hyaluronan. Br J Surg. 2003;90:533–541
  10. Buyne OR, van GH, Bleichrodt RP, Verweij PE, Hendriks T. Both tissue-type plasminogen activator and urokinase prevent intraabdominal abscess formation after surgical treatment of peritonitis in the rat. Surgery. 2008;144:66–73
  11. Buyne OR, Bleichrodt RP, van GH, Verweij PE, Hendriks T. Plasminogen activator, but not systemic antibiotic therapy, prevents abscess formation in an experimental model of secondary peritonitis. Br J Surg. 2008;95:1287–1293
  12. Li WY, Chong SS, Huang EY, Tuan TL. Plasminogen activator/plasmin system: a major player in wound healing?. Wound Repair Regen. 2003;11:239–247
  13. Evans DM, McAree K, Guyton DP, Hawkins N, Stakleff K. Dose dependency and wound healing aspects of the use of tissue plasminogen activator in the prevention of intra-abdominal adhesions. Am J Surg. 1993;165:229–232
  14. Buyne OR, Bleichrodt RP, van Goor H, Verweij PE, Hendriks T. Tissue-type plasminogen activator prevents formation of intra-abdominal abscesses after surgical treatment of secondary peritonitis in a rat model. Int J Colorectal Dis. 2007;22:819–825
  15. Buyne OR, Bleichrodt RP, Verweij PE, Groenewoud HM, van Goor H, Hendriks T. A peritonitis model with low mortality and persisting intra-abdominal abscesses. Int J Exp Pathol. 2006;87:361–368
  16. Hendriks T, Mastboom WJ. Healing of experimental intestinal anastomoses. Parameters for repair. Dis Colon Rectum. 1990;33:891–901
  17. Posma LA, Bleichrodt RP, van GH, Hendriks T. Ischemia and prolonged reperfusion before anastomotic construction do not reduce wound strength in the rat intestine. Surgery. 2006;139:671–677
  18. Ikeda M, Sorimachi K, Akimoto K, Yasumura Y. Reversed-phase high-performance liquid chromatographic analysis of hydroxyproline and proline from collagen by derivatization with dabsyl chloride. J Chromatogr. 1993;621:133–138
  19. Rotstein OD. Role of fibrin deposition in the pathogenesis of intraabdominal infection. Eur J Clin Microbiol Infect Dis. 1992;11:1064–1068
  20. Laurens N, Koolwijk P, de Maat MP. Fibrin structure and wound healing. J Thromb Haemost. 2006;4:932–939
  21. van Veen SQ, Meijers JC, Levi M, van Gulik TM, Boermeester MA. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis. Shock. 2007;27:534–541
  22. van Goor H, de Graaf JS, Grond J, Sluiter WJ, van der MJ, Bom VJ, et al. Fibrinolytic activity in the abdominal cavity of rats with faecal peritonitis. Br J Surg. 1994;81:1046–1049
  23. Holmdahl L. The role of fibrinolysis in adhesion formation. Eur J Surg Suppl. 1997;24–31
  24. Haslinger B, Kleemann R, Toet KH, Kooistra T. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells. Kidney Int. 2003;63:2065–2074
  25. Houston KA, McRitchie DI, Rotstein OD. Tissue plasminogen activator reverses the deleterious effect of infection on colonic wound healing. Ann Surg. 1990;211:130–135
  26. van Goor H. In vitro studies on the effect of recombinant tissue plasminogen activator on the rat fibrinolytic system. Thesis: Fibrinolytic therapy in generalized peritonitis to prevent intraabdominal abscess formation. Nijmegen. 1996;125–134
  27. Menzies D, Ellis H. The role of plasminogen activator in adhesion prevention. Surg Gynecol Obstet. 1991;172:362–366
  28. van Goor H, Bom VJ, van der MJ, Sluiter WJ, Bleichrodt RP. Coagulation and fibrinolytic responses of human peritoneal fluid and plasma to bacterial peritonitis. Br J Surg. 1996;83:1133–1135
  29. Hartl WH, Wolf H, Schneider CP, Kuchenhoff H, Jauch KW. Secular trends in mortality associated with new therapeutic strategies in surgical critical illness. Am J Surg. 2007;194:535–541
  30. Abbas S. Resection and primary anastomosis in acute complicated diverticulitis, a systematic review of the literature. Int J Colorectal Dis. 2007;22:351–357
  31. Constantinides VA, Tekkis PP, Athanasiou T, Aziz O, Purkayastha S, Remzi FH, et al. Primary resection with anastomosis vs. Hartmann's procedure in nonelective surgery for acute colonic diverticulitis: a systematic review. Dis Colon Rectum. 2006;49:966–981
  32. Trompetas V. Emergency management of malignant acute left-sided colonic obstruction. Ann R Coll Surg Engl. 2008;90:181–186

 Supported by Radboud University Nijmegen Medical Centre.

PII: S0039-6060(09)00325-0

doi: 10.1016/j.surg.2009.04.028

Surgery
Volume 146, Issue 5 , Pages 939-946 , November 2009

Article Tools

* Image Usage & Resolution